XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2022

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity

The following table summarizes stock option activity during the nine months ended September 30, 2022:

						Shares						Weighted- Average  Exercise Price						Weighted- Average Remaining Contractual Term						Aggregate Intrinsic Value
						(in thousands)												(in years)						(in thousands)
Outstanding at December 31, 2021						4,369						5.07						5.10						$	132,721
Granted						—						—
Exercised						(1,712)						3.11
Cancelled/forfeited						(143)						12.14
Outstanding at September 30, 2022						2,514						6.01						5.10						$	9,912
Vested and exercisable at September 30, 2022						2,328						5.58						5.00						$	9,805

Schedule of Restricted Stock Units

The following table summarizes RSU activity during the nine months ended September 30, 2022:

						Number of Shares						Weighted-Average  Grant Date Fair Value Per Share
						(in thousands)
Unvested RSUs as of December 31, 2021						5,285						$	42.80
Granted						11,088						15.00
Vested						(1,918)						35.41
Cancelled/forfeited						(1,474)						32.54
Unvested RSUs as of September 30, 2022						12,981						$	21.32

The following table summarizes the activity related to the revest shares during the nine months ended September 30, 2022:

						Number of Shares						Weighted-Average Grant Date Fair Value Per Share
						(in thousands)
Unvested revest shares as of December 31, 2021						336						$	97.84
Granted						—						—
Modification of shares subject to revest						(224)						97.84
Vested						(112)						97.84
Cancelled/forfeited						—						—
Unvested revest shares as of September 30, 2022						—						$	—

Schedule of Stock-Based Compensation Expense

The following table summarizes the components of total stock-based compensation expense included in the accompanying Condensed Consolidated Statements of Operations:

						Three months ended September 30,												Nine months ended September 30,
						2022						2021						2022						2021
						(in thousands)
Cost of revenue						$	2,978					$	1,897					$	9,112					$	4,911
Research and development						14,488						14,752						46,966						31,344
Sales and marketing						10,920						9,121						31,198						19,760
General and administrative						10,992						10,866						27,102						44,885
Total stock-based compensation expense						$	39,378					$	36,636					$	114,378					$	100,900

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration